ClinicalTrials.gov
public full text
Public Domain
A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS
The primary purpose of this study is to evaluate the safety and tolerability of arimoclomol in ALS patients following 90 days of dosing. In addition, the amount of arimoclomol in blood and cerebrospinal fluid will be measured.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Riluzole Oral Soluble Film Safety and Tolerability in Amyotrophic Lateral Sclerosis#911913
- Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS)#1339439
- Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)#885792
- Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis#1229207
- Safety, Tolerability and Pharmacokinetics of BI 44370 TA Oral Drinking Solution in Healthy Male Volunteers#895116
Record · ID 1185000
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive